Role of the cholinesterase inhibitors in the treatment of schizophrenia

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.22, Iss.3, 2013-03, pp. : 293-298

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacoeconomics of Cholinesterase Inhibitors in the Treatment of Alzheimers Disease

By Jönsson L.

PharmacoEconomics, Vol. 21, Iss. 14, 2003-01 ,pp. : 1025-1037

Adis International

Access to resources Recommend Favorite

Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease in the Elderly

By vandenBerg C.M. Kazmi Y. Jann M.W.

Drugs & Aging, Vol. 16, Iss. 2, 2000-02 ,pp. : 123-138

Adis International

Access to resources Recommend Favorite

Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists

By Friedman Joseph

Psychopharmacology, Vol. 174, Iss. 1, 2004-06 ,pp. : 45-53

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of Cognitive Deficits Associated with Schizophrenia: Potential Role of Catechol-O-Methyltransferase Inhibitors

By Apud José A. Weinberger Daniel R.

CNS Drugs, Vol. 21, Iss. 7, 2007-01 ,pp. : 535-557

Adis International

Access to resources Recommend Favorite

The Role of Bridging Studies in the Development of Cholinesterase Inhibitors for Alzheimers Disease

By Cutler N.R. Sramek J.J.

CNS Drugs, Vol. 10, Iss. 5, 1998-11 ,pp. : 355-364

Adis International

Access to resources Recommend Favorite